Literature DB >> 34164312

Near-infrared laparoscopy with indocyanine green for axillary sentinel lymph node biopsy in early breast cancer: preliminary experience of a single unit.

Ping Yang1, Xi'e Hu1, Shujia Peng1, Lu Wang1, Lin Yang1, Yanming Dong1, Zhenyu Yang1, Lijuan Yuan1, Huadong Zhao1, Xianli He1, Guoqiang Bao1.   

Abstract

BACKGROUND: A sentinel lymph node biopsy (SLNB) is a routine procedure for axillary staging in cN0 breast cancer (BC) patients. Indocyanine green (ICG) fluorescence can detect sentinel lymph nodes with higher sensitivity than carbon nanoparticle suspension (CNS). The present study investigated the availability and benefits of a near-infrared (NIR) laparoscopy-assisted SLNB using ICG and carbon nanoparticle suspension as tracers.
METHODS: Forty patients with invasive BC, who had clinically negative axillary lymph nodes, participated in this observational study. ICG and CNS tracers were injected into the periareolar region simultaneously or sequentially. In the endoscopy-assisted group (n=20), the patients were given NIR laparoscopic SLNB based on ICG fluorescence and CNS staining. In the open-surgery group, the patients were given traditional SLNB using an open incision, and CNS tracers were injected into the same region as that in the endoscopy-assisted group.
RESULTS: In the endoscopy-assisted group, lymphatic vessels and sentinel lymph nodes (SLNs) were successfully identified using ICG fluorescence imaging in most patients (19/20). The average number of SLNs removed was 2.85 (range, 1-4) in the endoscopy-assisted group, and 3.40 (range, 1-7) in the open-surgery group. There was no significant difference between the number of detected nodes (P=0.30). The patients who underwent endoscopy-assisted SLNBs had similar operating times, blood loss and hospital-stay lengths, but lower postoperative drainage volumes and higher satisfaction scores, as they did not have axillary incisions.
CONCLUSIONS: The NIR laparoscopy-assisted ICG-guided technique is a feasible and surgeon-friendly method for SLNB with good efficacy and acceptable safety. When combined with CNS, more SLNs can be detected and dissected. 2021 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Breast cancer (BC); carbon nanoparticles; indocyanine green (ICG); near-infrared fluorescence laparoscopy; sentinel lymph node biopsy (SLNB)

Year:  2021        PMID: 34164312      PMCID: PMC8184382          DOI: 10.21037/gs-21-223

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  53 in total

1.  A Novel Navigation for Laparoscopic Anatomic Liver Resection Using Indocyanine Green Fluorescence.

Authors:  Takeo Nomi; Daisuke Hokuto; Takahiro Yoshikawa; Yasuko Matsuo; Masayuki Sho
Journal:  Ann Surg Oncol       Date:  2018-09-14       Impact factor: 5.344

Review 2.  Endoscopic-assisted surgery in the management of breast cancer: 20 years review of trend, techniques and outcomes.

Authors:  Chi Wei Mok; Hung-Wen Lai
Journal:  Breast       Date:  2019-05-20       Impact factor: 4.380

3.  Clinical utility of the additional use of blue dye for indocyanine green for sentinel node biopsy in breast cancer.

Authors:  Yinan Ji; Ningbin Luo; Yi Jiang; Qiuyun Li; Wei Wei; Huawei Yang; Jianlun Liu
Journal:  J Surg Res       Date:  2017-04-01       Impact factor: 2.192

4.  Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer.

Authors:  Takashi Hojo; Tomoya Nagao; Mizuho Kikuyama; Sadako Akashi; Takayuki Kinoshita
Journal:  Breast       Date:  2010-02-13       Impact factor: 4.380

5.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.

Authors:  Armando E Giuliano; Kelly K Hunt; Karla V Ballman; Peter D Beitsch; Pat W Whitworth; Peter W Blumencranz; A Marilyn Leitch; Sukamal Saha; Linda M McCall; Monica Morrow
Journal:  JAMA       Date:  2011-02-09       Impact factor: 56.272

6.  Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence.

Authors:  D Murawa; C Hirche; S Dresel; M Hünerbein
Journal:  Br J Surg       Date:  2009-11       Impact factor: 6.939

7.  Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer.

Authors:  Anna M Derossis; Jane V Fey; Hiram S Cody; Patrick I Borgen
Journal:  J Am Coll Surg       Date:  2003-12       Impact factor: 6.113

8.  Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study.

Authors:  Jiajia Guo; Houpu Yang; Shu Wang; Yingming Cao; Miao Liu; Fei Xie; Peng Liu; Bo Zhou; Fuzhong Tong; Lin Cheng; Hongjun Liu; Siyuan Wang
Journal:  World J Surg Oncol       Date:  2017-11-02       Impact factor: 2.754

9.  Comparative study of indocyanine green combined with blue dye with methylene blue only and carbon nanoparticles only for sentinel lymph node biopsy in breast cancer.

Authors:  Xingsong Qin; Muwen Yang; Xinyu Zheng
Journal:  Ann Surg Treat Res       Date:  2019-06-26       Impact factor: 1.859

10.  Clinical feasibility of imaging with indocyanine green combined with carbon nanoparticles for sentinel lymph node identification in papillary thyroid microcarcinoma.

Authors:  Xing Zhang; Yan-Ping Shen; Jia-Gen Li; Gun Chen
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.